| Management of dyslipidaemia in patients with coronary heart disease: results from the ESC-EORP EUROASPIRE V survey in 27 countries G De Backer, P Jankowski, K Kotseva, E Mirrakhimov, Ž Reiner, L Ryden, ... Atherosclerosis 285, 135-146, 2019 | 303 | 2019 |
| Screening for glucose perturbations and risk factor management in dysglycemic patients with coronary artery disease—a persistent challenge in need of substantial improvement … G Ferrannini, D De Bacquer, G De Backer, K Kotseva, L Mellbin, D Wood, ... Diabetes care 43 (4), 726-733, 2020 | 54 | 2020 |
| Preventive cardiology, preclinical diagnoses: old problems–new approaches TV Ashcheulova, OAK OA, TG Ovrakh Inter Collegas 4 (1), 5-8, 2017 | 3 | 2017 |
| Impact of atorvastatin and rosuvastatin on residual on-clopidogrel treatment platelet reactivity in patients with ischemic heart disease and type 2 diabetes mellitus after … T Ovrakh, S Serik, O Kochubiei Georgian Medical News, 7-14, 2017 | 3 | 2017 |
| Цистатин С и его связь с возникновением сердечно-сосудистых событий у больных ишемической болезнью сердца в сочетании с сахарным диабетом 2 типа после перенесенного острого … СА Серик, ТГ Оврах Запорожский медицинский журнал, 302-307, 2019 | 2 | 2019 |
| Association of cystatin C with major adverse cardiac events in patients with type 2 diabetes mellitus after acute coronary syndrome T Ovrakh, S Serik Atherosclerosis 275, e198, 2018 | 2 | 2018 |
| The association between soluble suppression of tumorigenicity-2 and low-density lipoproteins level in patients with coronary heart disease and type 2 diabetes mellitus O Medentseva, I Rudyk, D Babichev, I Gasanov, T Ovrakh Atherosclerosis 331, e202, 2021 | 1 | 2021 |
| Возрастные особенности тромбоцитарного гемостаза на фоне двойной антитромбоцитарной терапии O Zaprovalna, TG Ovrakh, OV Tkachenko Практикуючий лікар, 70-72, 2013 | 1 | 2013 |
| ST2 prognostic value of unfavorable heart failure course in diabetic patients with HFpEF, 7.5 years follow-up OO Medentseva, IS Rudyk, TG Ovrakh, MM Udovychenko, DP Babichev, ... EUROPEAN JOURNAL OF HEART FAILURE 24, 54-54, 2022 | | 2022 |
| Dose-dependent effects of rosuvastatin on circulating microRNAs-27a and 221 levels in patients with coronary artery disease with type 2 diabetes mellitus S Serik, V Riabukha, E Serdobinska-Kanivets, T Bondar, T Ovrakh European Heart Journal 42 (Supplement_1), ehab724. 2942, 2021 | | 2021 |
| Association of soluble ST2, M235T polymorphism of ATG with insulin resistance in diabetic patients with heart failure with preserved ejection fraction O Medentseva, IS Rudyk, TG Ovrakh, IC Gasanov, DP Babichev, ... European Heart Journal 42 (Supplement_1), ehab724. 0992, 2021 | | 2021 |
| VEGF-A and circulating miсroRNA-221 levels in patients with ischemic heart disease with type 2 diabetes mellitus TG Ovrakh, S Serik, TA Chenchik, TN Bondar Atherosclerosis 331, e222, 2021 | | 2021 |
| ASSOCIATION BETWEEN TUMOR NECROSIS FACTOR, BRAIN NATRIURETIC PEPTIDE AND POLYMORPHISM OF THE M235T OF THE ATG GENE IN HYPERTENSIVE PATIENTS WITH HEART FAILURE O Medentseva, M Udovychenko, I Rudyk, T Ovrakh, I Gasanov, ... Journal of Hypertension 39, e109, 2021 | | 2021 |
| Association between vascular endothelial growth factor level and glycemic control in patients with coronary heart disease and type 2 diabetes mellitus TG Ovrakh, SA Serik, IR Komir Atherosclerosis 315, e202, 2020 | | 2020 |
| Inhibitors of the renin-angiotensin system in diabetic patients with heart failure with preserved ejection fraction treatment: impact of m235t polymorphism of angiotensinogen O Medentseva, IS Rudyk, MM Udovychenko, IC Gasanov, DP Babichev, ... EUROPEAN HEART JOURNAL 40, 120-120, 2019 | | 2019 |
| P322 Inhibitors of the renin-angiotensin system in diabetic patients with heart failure with preserved ejection fraction treatment: impact of m235t polymorphism of angiotensinogen O Medentseva, IS Rudyk, MM Udovychenko, IC Gasanov, DP Babichev, ... European Heart Journal 40 (Supplement_1), ehz747. 0157, 2019 | | 2019 |
| Specifics Of Expression Of Peroxisome Proliferator-Activated Receptors (Pparγ) Gene In Patients With Ihd Combined With Type 2 Diabetes Mellitus I Komir, S Seric, T Ovrakh, V Riabukha, V Strona Atherosclerosis 287, e272, 2019 | | 2019 |
| PREDICTION MODEL FOR CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION AND TYPE 2 DIABETES MELLITUS O Medentseva, M Udovychenko, I Rudyk, I Gasanov, T Ovrakh, ... Journal of Hypertension 37, e142, 2019 | | 2019 |
| Цистатин С и его связь с возникновением сердечно-сосудистых событий у больных ишемической болезнью сердца в сочетании с сахарным диабетом 2 типа после перенесенного острого … SA Serik, TH Ovrakh Запорізький медичний журнал, 2019 | | 2019 |
| P6523 M235T polymorphism of ATG: prognostic marker of cardiovascular events in diabetic patients with heart failure with preserved ejection fraction, a 2 year follow-up O Medentseva, IS Rudyk, MM Udovychenko, IG Kravchenko, SN Pivovar, ... European Heart Journal 39 (suppl_1), ehy566. P6523, 2018 | | 2018 |
